Economy

Microsoft Tops Q2 Estimates and Unveils Landmark UK AI Investment

Microsoft Corporation (NASDAQ: MSFT) is one of the 12 High-Risk High-Reward Growth Stocks to Consider Now. The tech titan has made headlines after exceeding analyst projections with robust Q2 financial

Your Trusted Source for Accurate and Timely Updates!

Our commitment to accuracy, impartiality, and delivering breaking news as it happens has earned us the trust of a vast audience. Stay ahead with real-time updates on the latest events, trends.

Lasted Economy

PG&E Unveils $73B Plan to Power AI Data Centers and Upgrade Grid by 2030

PG&E Corporation (NYSE:PCG) is regarded as one of the top stocks priced under $20. On September 29, PG&E Corporation revealed

Syndax’s Revumenib Added to NCCN AML Guidelines Ahead of October 25 FDA Decision

Syndax Pharmaceuticals Inc. (NASDAQ:SNDX) has emerged as a leading contender among the top stocks priced under $20. On September 19,

Peloton Launches ‘Pro Series’ Commercial Fitness Line, Including First Commercial Treadmill

Peloton Interactive Inc. (NASDAQ:PTON) has been recognized as one of the top stocks priced under $20. On October 1, the

BioCryst Sells European ORLADEYO Business for $250M Upfront to Focus on US Market

BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) ranks among the top stocks available for under $20. On October 1, BioCryst Pharmaceuticals declared the

Albertsons Launches Expedia-Powered ‘for U Travel’ for Grocery Cashback on Bookings

Albertsons Companies Inc. (NYSE:ACI) is being recognized as one of the top stocks priced below $20. On September 23, the

SentinelOne, Elpha Secure Partner on Integrated Cyber Insurance and Security for SMBs

SentinelOne Inc. (NYSE:S) has been recognized as one of the top stocks priced under $20. Recently, on October 2, the

Ford, GM Use Leasing ‘Loophole’ to Extend $7,500 EV Tax Credit

Ford Motor Company (NYSE:F) stands out as one of the top stocks valued under $20. On September 30, Ford and

Dyne’s Investigational DMD Drug DYNE-251 Gets Japan Orphan Drug Status After Strong Trial Data

Dyne Therapeutics Inc. (NASDAQ:DYN) stands out as one of the top stocks priced under $20. On September 29, the company